PCAF is an HIF-1alpha Cofactor That Regulates P53 Transcriptional Activity in Hypoxia

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2008 Jun 25

PMID 18574470

Citations 51

Authors

G Xenaki

T Ontikatze

R Rajendran

I J Stratford

C Dive

M Krstic-Demonacos

C Demonacos

Affiliations

Soon will be listed here.

Abstract

The p53 tumour suppressor is involved in several crucial cellular functions including cell-cycle arrest and apoptosis. p53 stabilization occurs under hypoxic and DNA damage conditions. However, only in the latter scenario is stabilized p53 capable of inducing the expression of its pro-apoptotic targets. Here we present evidence that under hypoxia-mimicking conditions p53 acetylation is reduced to a greater extent at K320 site targeted by P300/CBP-associated factor (PCAF) than at K382 site targeted by p300/CBP. The limited amounts of acetylated p53 at K320 are preferentially recruited to the promoter of the p21(WAF-1/CIP-1) gene, which appears to be unaffected by hypoxia, but are not recruited to the BID promoter and hence p53 is incapable of upregulating pro-apoptotic BID in hypoxic conditions. As the K320 p53 acetylation is the site predominantly affected in hypoxia, the PCAF histone acetyltransferase activity is the key regulator of the cellular fate modulated by p53 under these conditions. In addition, we provide evidence that PCAF acetylates hypoxia-inducible factor-1alpha (HIF-1alpha) in hypoxic conditions and that the acetylated HIF-1alpha is recruited to a particular subset of its targets. In conclusion, PCAF regulates the balance between cell-cycle arrest and apoptosis in hypoxia by modulating the activity and protein stability of both p53 and HIF-1alpha.

Citing Articles

Crosslinking-mediated Interactome Analysis Identified PHD2-HIF1α Interaction Hotspots and the Role of PHD2 in Regulating Protein Neddylation.

Ouyang H, How C, Wang X, Yu C, Luo A, Huang L bioRxiv. 2025; .

PMID: 39763868 PMC: 11702602. DOI: 10.1101/2024.12.16.628769.

Acetylation and Phosphorylation in the Regulation of Hypoxia-Inducible Factor Activities: Additional Options to Modulate Adaptations to Changes in Oxygen Levels.

Minisini M, Cricchi E, Brancolini C Life (Basel). 2024; 14(1).

PMID: 38276269 PMC: 10821055. DOI: 10.3390/life14010020.

Metformin Induces Apoptosis in Human Pancreatic Cancer (PC) Cells Accompanied by Changes in the Levels of Histone Acetyltransferases (Particularly, p300/CBP-Associated Factor (PCAF) Protein Levels).

Szymczak-Pajor I, Drzewoski J, Swiderska E, Strycharz J, Gabryanczyk A, Kasznicki J Pharmaceuticals (Basel). 2023; 16(1).

PMID: 36678613 PMC: 9863441. DOI: 10.3390/ph16010115.

Metabolite-derived protein modifications modulating oncogenic signaling.

Liu Y, Vandekeere A, Xu M, Fendt S, Altea-Manzano P Front Oncol. 2022; 12:988626.

PMID: 36226054 PMC: 9549695. DOI: 10.3389/fonc.2022.988626.

The role of epigenetic modifications in Colorectal Cancer Metastasis.

Su R, Wu X, Tao L, Wang C Clin Exp Metastasis. 2022; 39(4):521-539.

PMID: 35429301 PMC: 9338907. DOI: 10.1007/s10585-022-10163-w.

References

Demonacos C, Krstic-Demonacos M, Smith L, Xu D, OConnor D, Jansson M . A new effector pathway links ATM kinase with the DNA damage response. Nat Cell Biol. 2004; 6(10):968-76. DOI: 10.1038/ncb1170. View

Hammond E, Mandell D, Salim A, Krieg A, Johnson T, Shirazi H . Genome-wide analysis of p53 under hypoxic conditions. Mol Cell Biol. 2006; 26(9):3492-504. PMC: 1447427. DOI: 10.1128/MCB.26.9.3492-3504.2006. View

Goda N, Dozier S, Johnson R . HIF-1 in cell cycle regulation, apoptosis, and tumor progression. Antioxid Redox Signal. 2003; 5(4):467-73. DOI: 10.1089/152308603768295212. View

El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J . WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75(4):817-25. DOI: 10.1016/0092-8674(93)90500-p. View

Roy S, Packman K, Jeffrey R, Tenniswood M . Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells. Cell Death Differ. 2005; 12(5):482-91. DOI: 10.1038/sj.cdd.4401581. View

Erler J, Cawthorne C, Williams K, Koritzinsky M, Wouters B, Wilson C . Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol Cell Biol. 2004; 24(7):2875-89. PMC: 371100. DOI: 10.1128/MCB.24.7.2875-2889.2004. View

Hammond E, Giaccia A . The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun. 2005; 331(3):718-25. DOI: 10.1016/j.bbrc.2005.03.154. View

Sax J, Fei P, Murphy M, Bernhard E, Korsmeyer S, El-Deiry W . BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol. 2002; 4(11):842-9. DOI: 10.1038/ncb866. View

Ravi R, Mookerjee B, Bhujwalla Z, Sutter C, Artemov D, Zeng Q . Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 2000; 14(1):34-44. PMC: 316350. View

10.

Linares L, Kiernan R, Triboulet R, Chable-Bessia C, Latreille D, Cuvier O . Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol. 2007; 9(3):331-8. DOI: 10.1038/ncb1545. View

11.

Achison M, Hupp T . Hypoxia attenuates the p53 response to cellular damage. Oncogene. 2003; 22(22):3431-40. DOI: 10.1038/sj.onc.1206434. View

12.

Forsythe J, Jiang B, Iyer N, Agani F, Leung S, Koos R . Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996; 16(9):4604-13. PMC: 231459. DOI: 10.1128/MCB.16.9.4604. View

13.

You H, Pellegrini M, Tsuchihara K, Yamamoto K, Hacker G, Erlacher M . FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. J Exp Med. 2006; 203(7):1657-63. PMC: 2118330. DOI: 10.1084/jem.20060353. View

14.

Schmid T, Zhou J, Kohl R, Brune B . p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1). Biochem J. 2004; 380(Pt 1):289-95. PMC: 1224165. DOI: 10.1042/BJ20031299. View

15.

Hansson L, Friedler A, Freund S, Rudiger S, Fersht A . Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53. Proc Natl Acad Sci U S A. 2002; 99(16):10305-9. PMC: 124909. DOI: 10.1073/pnas.122347199. View

16.

Jeong J, Bae M, Ahn M, Kim S, Sohn T, Bae M . Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell. 2002; 111(5):709-20. DOI: 10.1016/s0092-8674(02)01085-1. View

17.

Chen D, Li M, Luo J, Gu W . Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem. 2003; 278(16):13595-8. DOI: 10.1074/jbc.C200694200. View

18.

Brunet A, Sweeney L, Sturgill J, Chua K, Greer P, Lin Y . Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004; 303(5666):2011-5. DOI: 10.1126/science.1094637. View

19.

Cory S, Huang D, Adams J . The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 2003; 22(53):8590-607. DOI: 10.1038/sj.onc.1207102. View

20.

Mahon P, Hirota K, Semenza G . FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001; 15(20):2675-86. PMC: 312814. DOI: 10.1101/gad.924501. View